BAXTER INTERNATIONAL INC (BAX)
Sector: Health Care
Named Executive Officers
Compensation data for top executives (showing up to 3 years of data)
| Executive | Year | Salary | Bonus | Stock Awards | Option Awards | Non-Equity Incentive Comp | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Andrew Hider President and CEO | 2025 | $499,315 | $1,000,000 | $23,133,518 | $3,185,053 | $820,125 | $1,167,171 | $29,805,182 |
| Executive | Year | Salary | Bonus | Stock Awards | Option Awards | Non-Equity Incentive Comp | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Joel Grade Former Executive Vice President and CFO | 2025 | $827,825 | $0 | $5,809,671 | $1,049,372 | $459,000 | $63,700 | $8,209,568 |
| 2024 | $810,000 | $500,000 | $4,295,702 | $0 | $839,608 | $62,238 | $6,507,548 | |
| 2023 | $164,384 | $0 | $3,636,661 | $902,897 | $167,671 | $4,608 | $4,876,222 |
| Executive | Year | Salary | Bonus | Stock Awards | Option Awards | Non-Equity Incentive Comp | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| José E. Almeida Former Chair of the Board, President and CEO | 2025 | $660,420 | $0 | $0 | $0 | $0 | $7,005,624 | $7,666,044 |
| 2024 | $1,300,000 | $0 | $14,319,107 | $0 | $2,016,300 | $435,608 | $18,071,015 | |
| 2023 | $1,300,000 | $0 | $7,527,469 | $2,635,170 | $2,187,900 | $136,132 | $13,786,671 |
| Executive | Year | Salary | Bonus | Stock Awards | Option Awards | Non-Equity Incentive Comp | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Heather Knight Former Executive Vice President, COO and Interim Group President, Medical Products & Therapies | 2025 | $747,123 | $0 | $4,018,281 | $1,267,349 | $0 | $41,795 | $6,074,548 |
| 2024 | $883,333 | $0 | $4,607,152 | $0 | $1,039,500 | $66,505 | $6,596,490 | |
| 2023 | $791,507 | $0 | $2,395,122 | $838,466 | $771,091 | $64,057 | $4,860,243 |
| Executive | Year | Salary | Bonus | Stock Awards | Option Awards | Non-Equity Incentive Comp | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Reazur Rasul Executive Vice President and Group President, Healthcare Systems & Technologies | 2025 | $800,000 | $0 | $2,953,421 | $931,507 | $488,000 | $73,286 | $5,246,214 |
| Executive | Year | Salary | Bonus | Stock Awards | Option Awards | Non-Equity Incentive Comp | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Alok Sonig Former Executive Vice President and Group President, Pharmaceuticals | 2025 | $779,747 | $0 | $3,375,371 | $1,064,578 | $0 | $19,577 | $5,239,273 |
| 2024 | $787,500 | $0 | $3,583,345 | $0 | $904,000 | $70,961 | $5,345,806 | |
| 2023 | $725,000 | $0 | $1,710,802 | $598,904 | $794,568 | $36,759 | $3,866,033 |
| Executive | Year | Salary | Bonus | Stock Awards | Option Awards | Non-Equity Incentive Comp | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Brent Shafer Non-Executive Chair and Former Executive Chair and Interim CEO | 2025 | $701,644 | $654,839 | $2,400,815 | $0 | $0 | $52,695 | $3,809,993 |
| Executive | Year | Salary | Bonus | Stock Awards | Option Awards | Non-Equity Incentive Comp | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| David Rosenbloom Executive Vice President and General Counsel | 2025 | $760,000 | $0 | $1,989,036 | $627,345 | $348,840 | $68,943 | $3,794,164 |
| Executive | Year | Salary | Bonus | Stock Awards | Option Awards | Non-Equity Incentive Comp | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Cecilia Soriano Group President, Infusion Therapies & Technologies and Pharmaceuticals | 2025 | $668,247 | $75,000 | $1,300,147 | $253,472 | $291,732 | $66,243 | $2,654,841 |